혈우병 A의 발병에 관여하는 유전적 요인 = Genetic Risk Factors of Hemophilia A

다국어 초록 (Multilingual Abstract)

Hemophilia A is a sex-linked recessive coagulation disorder associated with diverse mutations of the factor Ⅷ gene and a variety of phenotypes. The type of mutation involved dictates the activity of factor Ⅷ, and in turn the severity of bleeding episodes and development of alloantibodies against factor Ⅷ (inhibitors). Missense mutations are the most common genetic risk factors for hemophilia A, especially mild to moderate cases, but carry the lowest risk for inhibitor development. On the other hand, intron 22 inversion is the most common mutation associated with severe hemophilia A and is associated with high risk of inhibitor formation. Large deletions and nonsense mutations are also associated with high risk of inhibitor development. Additional mutations associated with hemophilia A include frameshift and splice site mutations. It is therefore valuable to assess the mutational backgrounds of hemophilia A patients in order to to interpret their symptoms and manage their health problems.

목차 (Table of Contents)

• 서론
• Ⅷ 인자 유전자와 Ⅷ 인자의 특성
• 혈우병 A 발병에 관여하는 유전자 이상
• Ⅷ 인자 항체 형성에 관여하는 유전자 이상
• 참고문헌

참고문헌 (Reference)

1 Rossetti LC, "homeologous recombination between AluSx-sequences as a cause of hemophilia" 24 : 440-440, 2004

2 Brinke A, "Two chimaeric transcription units result from an inversion breaking intron 1 of the factor VIII gene and a region reportedly affected by reciprocal translocations in T-cell leukaemia" 5 : 1945-1951, 1996

3 Dieijen G, "The role of phopholipid and factor VIIIa in the activation of bovine factor X" 256 : 3433-3442, 1981

4 Haldane JBS, "The rate of spontaneous mutation of a human gene" 31 : 317-317, 1935

5 Cooper DN, "The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions" 85 : 55-74, 1990

6 Lenting PJ, "The life cycle of coagulation factor VIII in view of its structure and function" 92 : 3983-3996, 1998

7 Darby SC, "The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99" 2 : 1047-1054, 2004

8 Mannucci PM, "The hemophilias - from royal genes to gene therapy" 344 : 1773-1779, 2001

9 Kemball-Cook G, "The factor VIII Structure and Mutation Resource Site:HAMSTeRS version 4" 26 : 216-219, 1998

10 Cooper DN, "The CpG dinucleotide and human genetic disease" 78 : 151-151, 1988

11 Vehar GA, "Structure of human factor VIII" 312 : 337-342, 1984

12 Weiss HJ, "Stabilization of Factor VIII in Plasma by the von Willebrand Factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease" 60 : 390-404, 1977

13 Nakaya SM, "Severe hemophilia A due to a 1.3kb factor VIII gene deletion including exon 24: homologous recombination between 41 bp within an Alu repeat sequence in introns 23 and 24" 2 : 1941-1945, 2004

14 Levinson B, "Sequence of the human factor VIII-associated gene is conserved in mouse" 13 : 862-865, 1992

15 Millar DS, "Screening for inversions in the factor VIII (F8) gene causing severe haemophilia A" 5 : 239-242, 1994

16 Saenko EL, "Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex" 9 : 185-192, 1999

17 Kaufman RJ, "Regulation of VIII expression and activity by von Willebrand factor" 82 : 201-208, 1999

18 Youssoufian H, "Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots" 324 : 380-382, 1986

19 Bagnall RD, "Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A" 99 : 168-174, 2002

20 Young M, "Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene" 60 : 565-573, 1997

21 Mikami S, "Nonsense mutations in factor VIII gene of a severe haemophiliac patient with anti-factor VIII antibody" 33 : 409-415, 1988

22 Woods-Samuels P, "Nonhomologous recombination in the human genome:deletions in the human factor VIII gene" 10 : 94-101, 1991

23 Antonarakis SE, "Molecular genetics of hemophilia A in man (factor VIII deficiency)" 4 : 81-94, 1987

24 Toole JJ, "Molecular cloning of a cDNA encoding human antihaemophilic factor" 312 : 342-347, 1984

25 Oldenburg J, "Molecular basis of haemophilia A" 10 : 133-139, 2004

26 Lanzkowsky P, "Manual of pediatric hematology and oncology. 4th ed" Elsevier academic press 312-312, 2005

27 Salviato R, "Large FVIII gene deletion confers very high risk of inhibitor development in three related severe haemophiliacs" 8 : 17-21, 2002

28 Sommer SS, "Is Alu-mediated recombination an important cause of hemophilia?" 88 : 3-4, 2002

29 Naylor JA, "Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions" 4 : 1217-1224, 1995

30 Lakich D, "Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A" 5 : 236-241, 1993

31 Brettler DB, "Inhibitors in congenital haemophilia" 9 : 319-329, 1996

32 Scharrer I, "Incidence of inhibitors in haemophiliacs. A review of the literature" 4 : 753-758, 1993

33 Ehrenforth S, "Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs" 71 : 594-598, 1992

34 Schwaab R, "Haemophilia A: mutation type determines risk of inhibitor formation" 74 : 1402-1406, 1995

35 Graw J, "Haemophilia A: from mutation analysis to new therapies" 6 : 488-501, 2005

36 Bolton-Maggs PH, "Haemophilia A and B" 361 : 1801-1809, 2003

37 O'Mahoney B, "Global haemophilia care challenge and opportunities: World Federation of Haemophilia"

38 Oldenburg J, "Genetic risk factors for inhibitors to factors VIII and IX" 12 : 15-22, 2006

39 Vidal F, "First molecular characterization of an unequal homologous alu-mediated recombination event responsible for hemophilia" 88 : 12-16, 2002

40 Vlot AJ, "Factor VIII and von Willebrand factor" 79 : 455-465, 1998

41 Saenko EL, "Factor VIII - novel insights into form and function" 119 : 323-331, 2002

42 Repesse Y, "Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development" 5 : 1469-1476, 2007

43 Kreuz W, "Escuriola-Ettingshausen C, Funk M, et al. Factor VIII Inhibitors in Patients with Hemophilia A: Epidemiology of Inhibitor Development and Induction of Immune Tolerance for Factor VIII" 21 : 382-389, 1995

44 Oldenburg J, "Environmental and genetic factors influencing inhibitors development" 41 : 82-88, 2004

45 White GC 2nd, "Definitions in hemophilia. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis" 85 : 560-560, 2001

46 Gitschier J, "Characterization of the human factor VIII gene" 312 : 326-330, 1984

47 Youssoufian H, "Characterization of five partial deletions of the factor VIII gene" 84 : 3772-3776, 1987

48 Bardoni B, "Characterization of a partial delation of the factor VIII gene in a haemophiliac with inhibitor" 79 : 86-88, 1988

49 Naylor J, "Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions" 2 : 1773-1778, 1993

50 Lollar P, "Activation of porcine factor VIII:C by thrombin and factor Xa" 24 : 8056-8064, 1985

51 Levinson B, "A transcribed gene in an intron of the human factor VIII gene" 7 : 1-11, 1990

52 Water N, "A 20.7 kb deletion within the factor VIII gene associated with LINE-1 element insertion" 79 : 938-942, 1998